title: Comparison of the rates of deamidation, diketopiperazine formation and oxidation in recombinant human vascular endothelial growth factor and model peptides.
abstract: In this work, we examine the way in which stability information obtained from studies on small model peptides correlates with similar information acquired from a protein. The rates of deamidation, oxidation, and diketopiperazine reactions in model peptide systems were compared to those of recombinant human vascular endothelial growth factor (rhVEGF). The N-terminal residues of rhVEGF, a potent mitogen in angiogenesis, are susceptible to the aforementioned reactions. The degradation of the peptides L-Ala-L-Pro-L-Met (APM) and Gly-L-Gln-L-Asn-L-His-L-His (GQNHH), residues 1-3 and 8-12 of rhVEGF, respectively, and rhVEGF were examined at pH 5 and 8 at 37 degrees C. Capillary electrophoresis and high-performance liquid chromatography (HPLC) stability-indicating assays were developed to monitor the degradation of the penta- and tripeptides, respectively. The degradation of rhVEGF was determined by tryptic mapping and quantified by RP-HPLC. The rates of degradation of both peptides and the protein followed apparent first-order kinetics and increased with increasing pH. The tripeptide APM underwent diketopiperazine formation (Ala-Pro-diketopiperazine) and oxidation of the Met residue, whereas the pentapeptide GQNHH degraded via the deamidation pathway. The results indicate that the rates of deamidation and oxidation of the protein are comparable to those observed in the model peptides at both pH values. However, the rate of the diketo-piperazine reaction was slower in the protein than in the model peptide, which may be the result of differences in the cis-trans equilibrium of the X-Pro peptide bonds in the 2 molecules.
authors.affiliation: Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Avenue, Lawrence, KS 66047, USA.
authors.forename: C
authors.initials: C
authors.lastname: Goolcharran
authors.forename: J L
authors.initials: JL
authors.lastname: Cleland
authors.forename: R
authors.initials: R
authors.lastname: Keck
authors.forename: A J
authors.initials: AJ
authors.lastname: Jones
authors.forename: R T
authors.initials: RT
authors.lastname: Borchardt
mesh_terms: D000577:Amides / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid; D054659:Diketopiperazines; D019075:Electrophoresis, Capillary; D016228:Endothelial Growth Factors / Q000737:chemistry*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008222:Lymphokines / Q000737:chemistry*; D009842:Oligopeptides / Q000737:chemistry*; D010084:Oxidation-Reduction; D010446:Peptide Fragments / Q000737:chemistry*; D010879:Piperazines / Q000737:chemistry*; D011994:Recombinant Proteins / Q000737:chemistry; D013696:Temperature; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D000577:Amides; D054659:Diketopiperazines; D016228:Endothelial Growth Factors; D008222:Lymphokines; D009842:Oligopeptides; D010446:Peptide Fragments; D010879:Piperazines; D011994:Recombinant Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors